cd38

  1. forestglip

    Causal Relationship Between Diet, Lipids, Immune Cells, and Chronic Fatigue Syndrome: A Two-Mediation Mendelian Randomization Study, 2025, Li et al

    Causal Relationship Between Diet, Lipids, Immune Cells, and Chronic Fatigue Syndrome: A Two-Mediation Mendelian Randomization Study Jixu Li, Qi Qin, Yiran Zhu, Yulu Qian, Jialu Yin, Xin Gao, Huijuan Wen, Pei Wang [Line breaks added] Abstract Chronic fatigue syndrome (CFS) is a disorder...
    • forestglip
    • Thread
    • alcohol apo b apoa1 apoe breakfast cd38 cheese chili peppers hdl igd ldl me/cfs mendelian randomization nk cells pork
    • Replies: 29
    • Forum: ME/CFS research
  2. John Mac

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1607353/abstract Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) entails low quality of life for patients and massive societal costs. There is an urgent need for elucidation of disease mechanisms...
  3. Kalliope

    Open Norway: Plasma cell aimed treatment with daratumumab in ME/CFS - Haukeland University Hospital

    The ME/CFS research team at Haukeland University Hospital in Bergen, Norway (Fluge, Mella, Rekeland, Sørland etc) is recruiting 66 participants for a new placebo-controlled trial on Daratumumab as a potential treatment for ME/CFS. The duration for participants is 72 weeks. The participants will...
  4. J

    Daratumumab, isatuximab (CD38 drugs)

    Commercialisation of HLX15 (daratumumab) https://www.businesswire.com/news/home/20250206161649/en/Dr.-Reddy’s-enters-into-collaboration-with-Henlius-for-commercialization-of-HLX15-daratumumab-a-biosimilar-candidate-to-Darzalex®-Darzalex-Faspro®-in-the-U.S.-and-Europe
Back
Top Bottom